Investors Grab APGE 37.6% Lower Than Its Secondary Stock Offering

Looking back to 116 days ago, Apogee Therapeutics Inc (APGE) priced a 6,774,193 share secondary stock offering at $62.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..